Works matching IS 02704137 AND DT 2021 AND VI 81 AND IP 7
Results: 10
What are survivorship care plans failing to tell men after prostate cancer treatment?
- Published in:
- Prostate, 2021, v. 81, n. 7, p. 398, doi. 10.1002/pros.24116
- By:
- Publication type:
- Article
Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer.
- Published in:
- Prostate, 2021, v. 81, n. 7, p. 433, doi. 10.1002/pros.24123
- By:
- Publication type:
- Article
Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients.
- Published in:
- Prostate, 2021, v. 81, n. 7, p. 427, doi. 10.1002/pros.24120
- By:
- Publication type:
- Article
Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative neoadjuvant trial in high‐risk localized prostate cancer.
- Published in:
- Prostate, 2021, v. 81, n. 7, p. 418, doi. 10.1002/pros.24118
- By:
- Publication type:
- Article
Periprostatic adipose tissue promotes prostate cancer resistance to docetaxel by paracrine IGF‐1 upregulation of TUBB2B beta‐tubulin isoform.
- Published in:
- Prostate, 2021, v. 81, n. 7, p. 407, doi. 10.1002/pros.24117
- By:
- Publication type:
- Article
Safety of concomitant therapy with radium‐223 and abiraterone or enzalutamide in a real‐world population.
- Published in:
- Prostate, 2021, v. 81, n. 7, p. 390, doi. 10.1002/pros.24115
- By:
- Publication type:
- Article
Postoperative peripheral neuropathies associated with patient positioning during robot‐assisted laparoscopic radical prostatectomy (RARP): A systematic review of the literature.
- Published in:
- Prostate, 2021, v. 81, n. 7, p. 361, doi. 10.1002/pros.24121
- By:
- Publication type:
- Article
Inhibition of human prostate stromal cell growth and smooth muscle contraction by thalidomide: A novel remedy in LUTS?
- Published in:
- Prostate, 2021, v. 81, n. 7, p. 377, doi. 10.1002/pros.24114
- By:
- Publication type:
- Article
Transcript analysis of commercial prostate cancer risk stratification panels in hard‐to‐predict grade group 2–4 prostate cancers.
- Published in:
- Prostate, 2021, v. 81, n. 7, p. 368, doi. 10.1002/pros.24108
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Prostate, 2021, v. 81, n. 7, p. 359, doi. 10.1002/pros.24005
- Publication type:
- Article